A study on herbal toothpastes reveals varying fluoride levels, antibacterial efficacy, and cytotoxicity, highlighting safety concerns in oral hygiene products.

5 Oct 2026

Patient navigators significantly improve postpartum care for low-income mothers

While the transition to motherhood can be challenging for anyone, barriers such as inadequate health literacy, unreliable transportation, navigating a complex health care system, limited access to childcare or insecure housing can be the tipping point between a new mom accessing needed care or going without it.

5 Oct 2026

Genetic links to ADHD, autism and depression changed with age

The study examines genetic liability for neurodevelopmental disorders, revealing its impact on social functioning and educational attainment across life stages.

5 Oct 2026

Doctors faced an AI-use penalty after disclosing AI use to patients

A study reveals that AI use by doctors can lead to negative perceptions, especially among younger patients, impacting trust and willingness to follow advice.

5 Oct 2026

Tracking health misinformation helps pediatricians provide targeted patient education

Pediatric clinicians can learn useful information by tracking the health misinformation that their patients encounter, according to research presented during the American Academy of Pediatrics 2026 National Conference & Exhibition Oct. 2-6, 2026, at the San Diego Convention Center.

5 Oct 2026

Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027

o2h co-discovery has announced that the Cambridge × London Life Sciences Showcase will return for its second edition during J.P. Morgan Healthcare Week 2027 in San Francisco.

From o2h Group 5 Oct 2026

Working nights for years is linked to changes in body-clock genes

Chronic night shifts alter circadian gene activity in female healthcare workers.

5 Oct 2026

$Vitamin B12 deficiency was linked to higher fracture hazard after 50$

Vitamin B12 deficiency was linked to higher fracture hazard after 50

A study links abnormal vitamin B12 levels to fracture risk, highlighting a complex relationship beyond simple deficiency in middle-aged and older adults.

2 Oct 2026

Postpartum GLP-1 prescriptions rise sharply among U.S. women

More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.

1 Oct 2026

Faith leaders could help expand hypertension screening and education in Nigeria

A new study has shown that faith leaders would be willing to partner on hypertension screenings and education, despite challenges of past health collaborations.

1 Oct 2026

European study demonstrates feasibility of population-wide type 1 diabetes screening

New research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) reports on pilot screening programs for type 1 diabetes from 8 different countries, and the authors – a consortium including Dr Peter Achenbach and Professor Anette-Gabriele Ziegler from the Institute of Diabetes Research, Helmholtz Munich, Munich, Germany – say that screening should be rolled out across Europe, ideally with three testing window: 2-4 years, 6-8 years and 10-15 years.

1 Oct 2026

Robotic assisted hip and knee replacements shows no clear benefit over conventional methods

The NHS recently outlined plans to expand robotic surgery sevenfold by 2035, but initial findings from the first UK big data studies on this topic published by The BMJ suggest that robotic assisted hip and knee replacements offer no clear benefit over conventional surgery for implant survival, revision risk, or surgical complications.

1 Oct 2026

Kingston University joins major London partnership for health and social care research

Kingston University, London has joined a new London-wide partnership to deliver health and social care transformation through research.

1 Oct 2026

Mauritius becomes first country to reverse type 2 diabetes epidemic

New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that the small island nation of Mauritius is the first country in the world to prove it is reversing the type 2 diabetes epidemic using the objective gold standard testing method of the 2-hour oral glucose tolerance test (2 hour OGTT).

1 Oct 2026

Oxford study identifies top technology priorities for respiratory care

Inhalers that show when they are running out. Oxygen equipment light enough to take out of the house. Help telling whether breathlessness is anxiety or the start of a flare-up.

1 Oct 2026

GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health shows that, following a review and meta-analysis of available studies, use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs for diabetes and weight management in women living with diabetes is not associated with adverse pregnancy outcomes in most cases.

1 Oct 2026

Novel 'speech clock' can estimate a person's chronological age

A large study shows that machine-learning clocks based on speech can estimate chronological age and may also offer a window into brain aging, biological aging, cognitive health, cumulative burden, and dementia.

30 Sep 2026

Study connects food insecurity to mental health in young mothers

A new review of research from across sub-Saharan Africa found that inadequate access to food is linked to depression, suicide attempts, HIV vulnerabilities, and poorer sexual and reproductive health outcomes among adolescent mothers.

30 Sep 2026

UC San Diego receives funding to establish the Polysubstance Addiction Research Center

Researchers from University of California San Diego have received a $12.6 million award from the National Institute on Drug Abuse (NIDA) to establish the Polysubstance Addiction Research Center (PARC), a multidisciplinary center designed to uncover the biological factors that contribute to addiction across multiple substances.

30 Sep 2026

UVM receives historic contract to develop medical digital twins

What if doctors could test a customized treatment on a virtual version of a critically ill patient before administering it in real life? That's the promise of medical "digital twins."

30 Sep 2026